Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$261.28 /

+4.09 (+1.59%)

, AAPL

Apple

$134.58 /

+2.62 (+1.99%)

13:07
04/23/21
04/23
13:07
04/23/21
13:07

Microsoft releases preview version of Office 2021 for Mac, Office LTSC

In a blog post yesterday, Microsoft (MSFT) announced the commercial preview of Microsoft Office Long Term Servicing Channel for Windows and Office 2021 for Mac (AAPL). "The next perpetual version of Office for commercial customers is built specifically for organizations running regulated devices that cannot accept feature updates for years at a time, process control devices that are not connected to the internet in manufacturing facilities, and specialty systems that must stay locked in time and require a long-term servicing channel. Office LTSC will provide the familiar productivity tools you have experienced with Office 2019, now with faster performance and expanded accessibility," Microsoft said. Users can preview Office LTSC and Office 2021 for Mac starting April 22. Office LTSC will include features from past Office releases as well as a subset of new features already available in Microsoft 365 Apps for enterprise. Office LTSC, like Windows 10 LTSC, will be supported for five years and continue being governed by the Fixed Lifecycle Policy. Reference Link

MSFT

Microsoft

$261.28 /

+4.09 (+1.59%)

AAPL

Apple

$134.58 /

+2.62 (+1.99%)

  • 27

    Apr

  • 28

    Apr

  • 04

    May

  • 24

    May

MSFT Microsoft
$261.28 /

+4.09 (+1.59%)

04/22/21 Wolfe Research
Microsoft initiated with an Outperform at Wolfe Research
04/22/21 Exane BNP Paribas
Microsoft initiated with an Outperform at Exane BNP Paribas
04/21/21 Berenberg
Crowdstrike initiated with a Buy at Berenberg
04/21/21 BofA
Microsoft price target raised to $300 from $280 at BofA
AAPL Apple
$134.58 /

+2.62 (+1.99%)

04/21/21 Morgan Stanley
Apple shares 'on path to re-rate,' says Morgan Stanley
04/21/21 Canaccord
Apple refreshed product line supports positive thesis, says Canaccord
04/21/21 Bernstein
Apple event broader in scope than anticipated, says Bernstein
04/21/21 Atlantic Equities
Apple making push to fight Spotify for podcast creators, says Atlantic Equities

TODAY'S FREE FLY STORIES

Hot Stocks
Avenue Therapeutics trading resumes  07:30
06/14/21
06/14
07:30
06/14/21
07:30
ATXI

Avenue Therapeutics

$4.23 /

-0.14 (-3.20%)

 
ShowHide Related Items >><<
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

Upgrade
Boston Properties upgraded to Overweight from Neutral at Piper Sandler » 07:29
06/14/21
06/14
07:29
06/14/21
07:29
BXP

Boston Properties

$123.19 /

+0.56 (+0.46%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

05/25/21 Goldman Sachs
Boston Properties assumed with a Sell at Goldman Sachs
05/04/21 Argus
Boston Properties price target raised to $120 from $100 at Argus
04/19/21 Deutsche Bank
Boston Properties price target raised to $107 from $103 at Deutsche Bank
04/14/21 Mizuho
Boston Properties price target raised to $107 from $86 at Mizuho
BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

Initiation
iMedia Brands initiated with a Buy at B. Riley » 07:28
06/14/21
06/14
07:28
06/14/21
07:28
IMBI

iMedia Brands

$8.72 /

-0.28 (-3.11%)

B. Riley initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

05/26/21 Lake Street
iMedia Brands price target raised to $19 from $15 at Lake Street
05/25/21 Craig-Hallum
iMedia Brands price target raised to $20 from $15 at Craig-Hallum
03/23/21 Lake Street
iMedia Brands price target raised to $15 from $13 at Lake Street
02/11/21 DA Davidson
iMedia Brands price target raised to $19 from $12 at DA Davidson
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

  • 10
    Jun
  • 18
    Feb
  • 26
    Aug
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

Hot Stocks
G1 Therapeutics initiates PRESERVE 3, phase 2 study of cosela » 07:28
06/14/21
06/14
07:28
06/14/21
07:28
GTHX

G1 Therapeutics

$21.65 /

-0.25 (-1.14%)

, MKKGY

Merck KGaA

$37.59 /

-0.43 (-1.13%)

, PFE

Pfizer

$40.15 /

-0.54 (-1.33%)

G1 Therapeutics (GTHX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

MKKGY Merck KGaA
$37.59 /

-0.43 (-1.13%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

04/23/21 Cowen
G1 Therapeutics transferred with Outperform at Cowen
11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
MKKGY Merck KGaA
$37.59 /

-0.43 (-1.13%)

06/01/21 Berenberg
Merck KGaA price target raised to EUR 158 from EUR 150 at Berenberg
05/17/21 Deutsche Bank
Merck KGaA price target raised to EUR 155 from EUR 146 at Deutsche Bank
05/13/21 JPMorgan
Merck KGaA price target raised to EUR 165 from EUR 160 at JPMorgan
03/08/21 Morgan Stanley
Merck KGaA price target lowered to EUR 141 from EUR 143 at Morgan Stanley
PFE Pfizer
$40.15 /

-0.54 (-1.33%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

Upgrade
Hudson Pacific upgraded to Overweight from Neutral at Piper Sandler » 07:27
06/14/21
06/14
07:27
06/14/21
07:27
HPP

Hudson Pacific

$29.73 /

-0.225 (-0.75%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

05/25/21 Goldman Sachs
Hudson Pacific assumed with a Buy at Goldman Sachs
04/16/21 Morgan Stanley
Morgan Stanley downgrades Hudson Pacific to Underweight on SF market challenges
04/16/21 Morgan Stanley
Hudson Pacific downgraded to Underweight from Equal Weight at Morgan Stanley
04/14/21 Mizuho
Hudson Pacific price target raised to $28 from $23 at Mizuho
HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

Recommendations
OrthoPediatrics price target raised to $77 from $70 at Needham » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
KIDS

OrthoPediatrics

$63.38 /

+0.02 (+0.03%)

Needham analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

06/01/21 Piper Sandler
Piper Sandler 'strongly' encourages investors buy OrthoPediatrics
05/07/21 Truist
OrthoPediatrics price target raised to $72 from $64 at Truist
05/07/21 JMP Securities
OrthoPediatrics price target raised to $70 from $55 at JMP Securities
05/06/21 Piper Sandler
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

  • 18
    Jun
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

Initiation
Oatly Group initiated with a Neutral at JPMorgan » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
OTLY

Oatly Group

$28.71 /

+2.01 (+7.53%)

JPMorgan analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

07:15 Today Truist
Oatly Group initiated with a Buy at Truist
07:02 Today William Blair
Oatly Group initiated with an Outperform at William Blair
06:36 Today Guggenheim
Oatly Group initiated with a Buy at Guggenheim
06:24 Today Truist
Oatly Group initiated with a Buy at Truist
  • 20
    May
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

Hot Stocks
Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
LABP

Landos Biopharma

$12.06 /

-0.03 (-0.25%)

Landos Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

  • 04
    Feb
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

Downgrade
UWM Holdings downgraded to Neutral at Wedbush on stock current value » 07:24
06/14/21
06/14
07:24
06/14/21
07:24
UWMC

UWM Holdings

$10.23 /

+0.545 (+5.63%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

06:44 Today Wedbush
UWM Holdings downgraded to Neutral from Outperform at Wedbush
06/02/21 Credit Suisse
UWM Holdings downgraded to Neutral from Outperform at Credit Suisse
05/27/21 Argus
UWM Holdings initiated with a Buy at Argus
05/27/21 Argus
UWM Holdings initiated with a Buy at Argus
UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

Initiation
Squarespace initiated with an Overweight at JPMorgan » 07:24
06/14/21
06/14
07:24
06/14/21
07:24
SQSP

Squarespace

$59.94 /

+2.04 (+3.52%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

07:05 Today William Blair
Squarespace initiated with an Outperform at William Blair
06:43 Today Raymond James
Squarespace initiated with an Outperform at Raymond James
06:14 Today Piper Sandler
Squarespace initiated with a Neutral at Piper Sandler
06:12 Today RBC Capital
Squarespace initiated with a Sector Perform at RBC Capital
  • 19
    May
SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

Hot Stocks
Enochian Biosciences announces FDA acceptance of pre-IND for potential HIV cure » 07:23
06/14/21
06/14
07:23
06/14/21
07:23
ENOB

Enochian Biosciences

$4.38 /

-0.02 (-0.45%)

Enochian BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENOB Enochian Biosciences
$4.38 /

-0.02 (-0.45%)

ENOB Enochian Biosciences
$4.38 /

-0.02 (-0.45%)

Initiation
Procore initiated with an Overweight at JPMorgan » 07:21
06/14/21
06/14
07:21
06/14/21
07:21
PCOR

Procore

$83.98 /

-2.47 (-2.86%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$83.98 /

-2.47 (-2.86%)

07:04 Today William Blair
Procore initiated with an Outperform at William Blair
06:21 Today Canaccord
Procore initiated with a Buy at Canaccord
06:15 Today Oppenheimer
Procore initiated with an Outperform at Oppenheimer
06:09 Today Piper Sandler
Procore initiated with an Overweight at Piper Sandler
  • 20
    May
PCOR Procore
$83.98 /

-2.47 (-2.86%)

PCOR Procore
$83.98 /

-2.47 (-2.86%)

Hot Stocks
iTeos Therapeutics, GlaxoSmithKline collaborate for EOS-448 » 07:21
06/14/21
06/14
07:21
06/14/21
07:21
ITOS

iTeos Therapeutics

$20.01 /

+0.11 (+0.55%)

, GSK

GlaxoSmithKline

$40.15 /

-0.07 (-0.17%)

iTeos Therapeutics (ITOS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

  • 24
    Jul
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

Recommendations
PDC Energy price target raised to $65 from $51 at JPMorgan » 07:20
06/14/21
06/14
07:20
06/14/21
07:20
PDCE

PDC Energy

$47.79 /

+0.6 (+1.27%)

JPMorgan analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

02/25/21 JPMorgan
PDC Energy price target raised to $47 from $30 at JPMorgan
01/21/21 JPMorgan
PDC has roadmap to narrow discount to intrinsic value, says JPMorgan
01/21/21 Citi
PDC Energy price target raised to $30 from $21 at Citi
01/19/21 Cowen
PDC Energy price target raised to $33 from $27 at Cowen
PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

Initiation
Halozyme initiated with an Outperform at Evercore ISI » 07:20
06/14/21
06/14
07:20
06/14/21
07:20
HALO

Halozyme

$42.82 /

+1.09 (+2.61%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
$42.82 /

+1.09 (+2.61%)

HALO Halozyme
$42.82 /

+1.09 (+2.61%)

06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
05/11/21 Piper Sandler
Halozyme downgraded to Neutral from Overweight at Piper Sandler
HALO Halozyme
$42.82 /

+1.09 (+2.61%)

HALO Halozyme
$42.82 /

+1.09 (+2.61%)

Initiation
Ingersoll-Rand reinstated with a Neutral at Credit Suisse » 07:19
06/14/21
06/14
07:19
06/14/21
07:19
IR

Ingersoll-Rand

$47.92 /

+0.52 (+1.10%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

05/19/21 Deutsche Bank
Deutsche Bank upgrades 'laggard' Ingersoll-Rand to Buy
05/19/21 Deutsche Bank
Ingersoll-Rand upgraded to Buy from Hold at Deutsche Bank
05/12/21 Evercore ISI
Ingersoll-Rand price target raised to $53 from $48 at Evercore ISI
04/06/21 Barclays
Ingersoll-Rand price target raised to $56 from $53 at Barclays
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

  • 11
    May
  • 17
    Jun
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

Upgrade
Krung Thai Bank upgraded to Neutral from Underweight at JPMorgan » 07:19
06/14/21
06/14
07:19
06/14/21
07:19
KTHAF

Krung Thai Bank

/

+

JPMorgan analyst Harsh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTHAF Krung Thai Bank
/

+

09/09/20 Goldman Sachs
Krung Thai Bank upgraded to Neutral from Sell at Goldman Sachs
Hot Stocks
Global Blood Therapeutics receives PIM designation for voxelotor from UK » 07:17
06/14/21
06/14
07:17
06/14/21
07:17
GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

Global Blood Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

Recommendations
Eli Lilly price target raised to $270 from $252 at Goldman Sachs » 07:17
06/14/21
06/14
07:17
06/14/21
07:17
LLY

Eli Lilly

$224.12 /

-9.42 (-4.03%)

, BIIB

Biogen

$396.46 /

-18.29 (-4.41%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
05/24/21 H.C. Wainwright
Aurinia reported positive data as competitors 'stumble,' says H.C. Wainwright
BIIB Biogen
$396.46 /

-18.29 (-4.41%)

07:14 Today Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
06/11/21
Fly Intel: Top five analyst upgrades
06/11/21 Bernstein
Biogen upgraded to Outperform from Market Perform at Bernstein
06/11/21 RBC Capital
Prothena price target raised to $50 from $28 at RBC Capital
LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

LLY Eli Lilly
$224.12 /

-9.42 (-4.03%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

Initiation
Oatly Group initiated with a Buy at Truist » 07:15
06/14/21
06/14
07:15
06/14/21
07:15
OTLY

Oatly Group

$28.71 /

+2.01 (+7.53%)

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

07:02 Today William Blair
Oatly Group initiated with an Outperform at William Blair
06:36 Today Guggenheim
Oatly Group initiated with a Buy at Guggenheim
06:24 Today Truist
Oatly Group initiated with a Buy at Truist
06:17 Today Oppenheimer
Oatly Group initiated with a Perform at Oppenheimer
  • 20
    May
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

Hot Stocks
Boxed to become US publicly traded company through merger with Seven Oaks SPAC » 07:14
06/14/21
06/14
07:14
06/14/21
07:14
SVOK

Seven Oaks Acquisition

$9.81 /

+0.06 (+0.62%)

Boxed, an e-commerce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVOK Seven Oaks Acquisition
$9.81 /

+0.06 (+0.62%)

Recommendations
Biogen price target raised to $436 from $246 at Goldman Sachs » 07:14
06/14/21
06/14
07:14
06/14/21
07:14
BIIB

Biogen

$396.46 /

-18.29 (-4.41%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

06/11/21
Fly Intel: Top five analyst upgrades
06/11/21 Bernstein
Biogen upgraded to Outperform from Market Perform at Bernstein
06/11/21 RBC Capital
Prothena price target raised to $50 from $28 at RBC Capital
06/11/21 Bernstein
Biogen upgraded to Outperform from Market Perform at Bernstein
BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

BIIB Biogen
$396.46 /

-18.29 (-4.41%)

Hot Stocks
Avenue Therapeutics receives complete response letter from FDA for IV tramadol » 07:10
06/14/21
06/14
07:10
06/14/21
07:10
ATXI

Avenue Therapeutics

$4.23 /

-0.14 (-3.20%)

Avenue Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

Recommendations
Ascendis's TransCon GH still likely to gain approval, says Cantor Fitzgerald » 07:10
06/14/21
06/14
07:10
06/14/21
07:10
ASND

Ascendis Pharma

$130.26 /

+1.7 (+1.32%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

06:28 Today Morgan Stanley
Ascendis Pharma price target lowered to $197 from $201 at Morgan Stanley
06/01/21 Canaccord
Ascendis Pharma price target raised to $196 from $190 at Canaccord
05/26/21 JPMorgan
Ascendis should be bought into second half catalysts, says JPMorgan
05/11/21 JPMorgan
Ascendis shares offer 'very compelling entry point,' says JPMorgan
ASND Ascendis Pharma
$130.26 /

+1.7 (+1.32%)

  • 08
    Jul
Hot Stocks
Moderna submits application to Swissmedic for COVID-19 vaccine in adolescents » 07:10
06/14/21
06/14
07:10
06/14/21
07:10
MRNA

Moderna

$218.69 /

+1.59 (+0.73%)

Moderna announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
MRNA Moderna
$218.69 /

+1.59 (+0.73%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

MRNA Moderna
$218.69 /

+1.59 (+0.73%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.